09/09/2025 | Press release | Archived content
Fried Frank acted as counsel to Merck & Co., Inc., as issuer, in its $6 billion, six-tranche registered public offering of US dollar-denominated senior notes. Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
The Fried Frank team was led by corporate partners Daniel J. Bursky and Andrew B. Barkan.